|
EP1594542B1
(en)
|
2003-02-20 |
2010-06-30 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer
|
|
DK2099823T4
(da)
|
2006-12-01 |
2022-05-09 |
Seagen Inc |
Målbindingsmiddelvarianter og anvendelser deraf
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
IL295601B2
(en)
|
2009-02-05 |
2024-11-01 |
Immunogen Inc |
Benzodiazepine Derivatives and Processes for Producing the Same
|
|
MX2012011900A
(es)
|
2010-04-15 |
2013-03-21 |
Seattle Genetics Inc |
Conjugados de pirrolobenzodiazepina diana.
|
|
CN102971329B
(zh)
|
2010-04-15 |
2016-06-29 |
麦迪穆有限责任公司 |
用于治疗增殖性疾病的吡咯并苯并二氮杂卓
|
|
WO2012112687A1
(en)
|
2011-02-15 |
2012-08-23 |
Immunogen, Inc. |
Methods of preparation of conjugates
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
CA2849039C
(en)
|
2011-09-20 |
2018-09-18 |
Spirogen Sarl |
Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
|
|
US9388187B2
(en)
|
2011-10-14 |
2016-07-12 |
Medimmune Limited |
Pyrrolobenzodiazepines
|
|
BR112014008888A2
(pt)
|
2011-10-14 |
2017-04-18 |
Seattle Genetics Inc |
pirrolobenzodiazepinas
|
|
WO2013055990A1
(en)
|
2011-10-14 |
2013-04-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
BR112014009055B1
(pt)
|
2011-10-14 |
2021-12-14 |
Seattle Genetics, Inc. |
Compostos pirrolobenzodiazepinas, conjugados alvos, ligante de fármaco e uso dos ditos conjugados para tratar uma doença proliferativa
|
|
CN104520324A
(zh)
|
2012-02-24 |
2015-04-15 |
施特姆森特Rx股份有限公司 |
Dll3调节剂及其使用方法
|
|
NZ631197A
(en)
|
2012-02-24 |
2017-05-26 |
Abbvie Stemcentrx Llc |
Anti sez6 antibodies and methods of use
|
|
US20130309223A1
(en)
*
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
CA2887896A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-her2 antibody conjugates
|
|
WO2014057113A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine - anti-psma antibody conjugates
|
|
DK2906248T3
(en)
*
|
2012-10-12 |
2019-03-04 |
Medimmune Ltd |
Pyrrolobenzodiazepines and their conjugates
|
|
AU2013328628B2
(en)
*
|
2012-10-12 |
2016-12-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-anti-CD22 antibody conjugates
|
|
SMT201800346T1
(it)
*
|
2012-10-12 |
2018-09-13 |
Medimmune Ltd |
Coniugati pirrolobenzodiazepina-anticorpo
|
|
EP2906250B1
(en)
*
|
2012-10-12 |
2018-05-30 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
EP2906297B1
(en)
|
2012-10-12 |
2017-12-06 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
LT2906298T
(lt)
*
|
2012-10-12 |
2018-12-27 |
Adc Therapeutics Sa |
Pirolbenzodiazepino-antikūno konjugatai
|
|
PT2839860T
(pt)
|
2012-10-12 |
2019-07-29 |
Medimmune Ltd |
Pirrolobenzodiazepinas e conjugados das mesmas
|
|
AU2013328673B2
(en)
|
2012-10-12 |
2017-07-13 |
Medimmune Limited |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
WO2014057118A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
EP2917195B9
(en)
*
|
2012-11-05 |
2018-05-30 |
Pfizer Inc |
Spliceostatin analogs
|
|
US9353150B2
(en)
|
2012-12-04 |
2016-05-31 |
Massachusetts Institute Of Technology |
Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
|
|
US9567340B2
(en)
|
2012-12-21 |
2017-02-14 |
Medimmune Limited |
Unsymmetrical pyrrolobenzodiazepines-dimers for use in the treatment of proliferative and autoimmune diseases
|
|
EA031585B1
(ru)
|
2012-12-21 |
2019-01-31 |
Медимьюн Лимитед |
Пирролобензодиазепины и их конъюгаты
|
|
RU2684468C2
(ru)
*
|
2013-02-22 |
2019-04-09 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Новые конъюгаты антител и их применения
|
|
EP2970444A4
(en)
|
2013-03-13 |
2016-11-09 |
Seattle Genetics Inc |
CYCLODEXTRIN AND ANTIBODY ACTIVE CONJUGATE FORMULATIONS
|
|
PL2968494T3
(pl)
*
|
2013-03-13 |
2019-04-30 |
Seattle Genetics Inc |
Filtracja z węglem aktywnym do oczyszczania benzodiazepinowych ADC
|
|
NZ712035A
(en)
*
|
2013-03-13 |
2019-06-28 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CN105142674B
(zh)
|
2013-03-13 |
2018-11-13 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂卓和其结合物
|
|
JP6445519B2
(ja)
|
2013-03-13 |
2018-12-26 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
SG11201601005XA
(en)
*
|
2013-08-12 |
2016-03-30 |
Genentech Inc |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
EP3038634A4
(en)
|
2013-08-28 |
2017-10-11 |
AbbVie Stemcentrx LLC |
Novel sez6 modulators and methods of use
|
|
RU2016111137A
(ru)
*
|
2013-08-28 |
2017-10-03 |
ЭББВИ СТЕМСЕНТРКС ЭлЭлСи |
Сконструированные конъюгаты против dll3 и способы применения
|
|
BR112016004242A8
(pt)
|
2013-08-28 |
2018-06-12 |
Stemcentrx Inc |
Métodos para conjugação sítio-específica de anticorpos e composições
|
|
WO2015028850A1
(en)
|
2013-09-02 |
2015-03-05 |
Hangzhou Dac Biotech Co., Ltd |
Novel cytotoxic agents for conjugation of drugs to cell binding molecule
|
|
JP6282745B2
(ja)
|
2013-09-12 |
2018-02-21 |
ハロザイム インコーポレイテッド |
修飾抗上皮成長因子受容体抗体およびその使用法
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317981D0
(en)
*
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3756663A1
(en)
|
2013-10-15 |
2020-12-30 |
Seagen Inc. |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
WO2015069794A2
(en)
|
2013-11-06 |
2015-05-14 |
Stem Centrx, Inc. |
Novel anti-claudin antibodies and methods of use
|
|
ES2753269T3
(es)
|
2013-11-25 |
2020-04-07 |
Seattle Genetics Inc |
Preparación de anticuerpos a partir del cultivo de células CHO para conjugación
|
|
MX2016007369A
(es)
|
2013-12-12 |
2016-09-08 |
Stemcentrx Inc |
Nuevos anticuerpos anti-dpep3 y metodos de uso.
|
|
CA2929565A1
(en)
|
2013-12-16 |
2015-06-25 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
KR20240010081A
(ko)
|
2013-12-19 |
2024-01-23 |
씨젠 인크. |
표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커
|
|
AU2015218633A1
(en)
|
2014-02-21 |
2016-09-01 |
Abbvie Stemcentrx Llc |
Anti-DLL3 antibodies and drug conjugates for use in melanoma
|
|
CN115322253A
(zh)
|
2014-03-20 |
2022-11-11 |
百时美施贵宝公司 |
稳定化的基于纤连蛋白的支架分子
|
|
TWI684600B
(zh)
|
2014-03-21 |
2020-02-11 |
美商艾伯維有限公司 |
抗－ｅｇｆｒ抗體及抗體藥物結合物
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
TW201617368A
(zh)
|
2014-09-05 |
2016-05-16 |
史坦森特瑞斯公司 |
新穎抗ｍｆｉ２抗體及使用方法
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2016040723A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Anti-her2 antibodies and immunoconjugates
|
|
BR112017010094A2
(pt)
|
2014-11-21 |
2018-02-06 |
Bristol-Myers Squibb Company |
anticorpos compreendendo regiões constantes de cadeias pesadas modificadas
|
|
EA035766B1
(ru)
|
2014-11-21 |
2020-08-07 |
Бристол-Майерс Сквибб Компани |
Антитело к cd73 и его применения
|
|
EP3223854A1
(en)
|
2014-11-25 |
2017-10-04 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3702367B1
(en)
|
2014-11-25 |
2024-05-15 |
Bristol-Myers Squibb Company |
Novel pd-l1 binding polypeptides for imaging
|
|
US9527871B2
(en)
|
2015-01-14 |
2016-12-27 |
Bristol-Myers Squibb Company |
Benzodiazepine dimers, conjugates thereof, and methods of making and using
|
|
JP6676058B2
(ja)
|
2015-01-14 |
2020-04-08 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
ヘテロアリーレン架橋したベンゾジアゼピン二量体、そのコンジュゲート、ならびに製造および使用方法
|
|
CN107406496A
(zh)
|
2015-03-10 |
2017-11-28 |
百时美施贵宝公司 |
可通过转谷氨酰胺酶缀合的抗体和由其制备的缀合物
|
|
WO2016164916A1
(en)
|
2015-04-10 |
2016-10-13 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory m2 monocytes
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
PT3303396T
(pt)
|
2015-05-29 |
2023-01-30 |
Bristol Myers Squibb Co |
Anticorpos contra ox40 e utilizações dos mesmos
|
|
TW201709932A
(zh)
|
2015-06-12 |
2017-03-16 |
西雅圖遺傳學公司 |
Ｃｄ１２３抗體及其共軛物
|
|
BR112017027258A2
(pt)
|
2015-06-23 |
2018-08-28 |
Bristol-Myers Squibb Company |
dímeros de benzodiazepina macrocíclicos, conjugados dos mesmos, preparação e usos
|
|
PL3316909T3
(pl)
|
2015-06-30 |
2023-11-20 |
Seagen Inc. |
Przeciwciała anty-ntb-a i powiązane kompozycje i sposoby
|
|
IL283355B
(en)
|
2015-07-21 |
2022-08-01 |
Immunogen Inc |
Methods for the preparation of cytotoxic benzodiazepine compounds
|
|
EP3353198B1
(en)
|
2015-09-23 |
2020-06-17 |
Bristol-Myers Squibb Company |
Glypican-3binding fibronectin based scafflold molecules
|
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
|
SI3380124T1
(sl)
*
|
2015-11-25 |
2024-10-30 |
Legochem Biosciences, Inc. |
Konjugati, ki obsegajo samožrtvujoče skupine in z njimi povezani postopki
|
|
US10195209B2
(en)
|
2015-11-30 |
2019-02-05 |
Abbvie Inc. |
Anti-huLRRC15 antibody drug conjugates and methods for their use
|
|
EP3383909B1
(en)
|
2015-11-30 |
2020-06-17 |
AbbVie Inc. |
Anti-human lrrc15 antibody drug conjugates and methods for their use
|
|
MX2018006218A
(es)
|
2015-12-04 |
2018-09-05 |
Seattle Genetics Inc |
Conjugados de compuestos de tubulisina cuaternizada.
|
|
AU2016364853A1
(en)
*
|
2015-12-04 |
2018-06-21 |
Abbvie Stemcentrx Llc |
Novel anti-claudin antibodies and methods of use
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
GB201521709D0
(en)
*
|
2015-12-09 |
2016-01-20 |
Kings College London And Sec Dep For Health The |
PBD Antibacterial agents
|
|
AU2016377371A1
(en)
|
2015-12-21 |
2018-08-09 |
Bristol-Myers Squibb Company |
Variant antibodies for site-specific conjugation
|
|
GB201601431D0
(en)
*
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
CN109476740A
(zh)
|
2016-03-04 |
2019-03-15 |
百时美施贵宝公司 |
利用抗cd73抗体的联合治疗
|
|
WO2017160954A1
(en)
|
2016-03-15 |
2017-09-21 |
Seattle Genetics, Inc. |
Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors
|
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
|
EA201892040A1
(ru)
|
2016-03-25 |
2019-04-30 |
Сиэтл Дженетикс, Инк. |
Способ получения пегилированных соединений лекарственный препарат - линкер и их промежуточных соединений
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
US20190117787A1
(en)
*
|
2016-04-15 |
2019-04-25 |
Seattle Genetics, Inc. |
Combinations of cd33 antibody drug conjugates with hypomethylating agents
|
|
WO2017184942A1
(en)
|
2016-04-21 |
2017-10-26 |
Abbvie Stemcentrx Llc |
Novel anti-bmpr1b antibodies and methods of use
|
|
GB201607478D0
(en)
*
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
WO2017201132A2
(en)
|
2016-05-18 |
2017-11-23 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3463463A4
(en)
|
2016-06-03 |
2020-01-15 |
Seattle Genetics, Inc. |
Combination of cd33 antibody drug conjugates with chemotherapeutic agents
|
|
BR112018075630A2
(pt)
|
2016-06-08 |
2019-03-19 |
Abbvie Inc. |
anticorpos anti-cd98 e conjugados de fármaco de anticorpo
|
|
MY199278A
(en)
|
2016-06-08 |
2023-10-24 |
Abbvie Inc |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗ｂｈ７−ｈ３抗体及び抗体薬物コンジュゲート
|
|
EP3468993A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
EP3468599A2
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
US11191771B2
(en)
|
2016-06-09 |
2021-12-07 |
Seagen Inc. |
Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors
|
|
CA3028145A1
(en)
|
2016-06-17 |
2017-12-21 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of cells
|
|
TWI760344B
(zh)
|
2016-06-24 |
2022-04-11 |
美商梅爾莎納醫療公司 |
吡咯並苯並二氮呯類和彼等之共軛物類
|
|
WO2018048975A1
(en)
|
2016-09-09 |
2018-03-15 |
Bristol-Myers Squibb Company |
Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
GB201619490D0
(en)
*
|
2016-11-17 |
2017-01-04 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CA3047115A1
(en)
|
2016-12-16 |
2018-06-21 |
Bluefin Biomedicine, Inc. |
Anti-cub domain-containing protein 1 (cdcp1) antibodies, antibody drug conjugates, and methods of use thereof
|
|
SG10202107429WA
(en)
|
2017-01-06 |
2021-08-30 |
Avidity Biosciences Inc |
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
|
|
MA47331A
(fr)
|
2017-01-20 |
2019-11-27 |
Magenta Therapeutics Inc |
Compositions et procédés pour la déplétion des cellules cd137+
|
|
RS62343B1
(sr)
|
2017-02-08 |
2021-10-29 |
Adc Therapeutics Sa |
Pirolobenzodiazepin-antitelo konjugati
|
|
US11160872B2
(en)
|
2017-02-08 |
2021-11-02 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
KR20240074000A
(ko)
|
2017-02-28 |
2024-05-27 |
다이이찌 산쿄 가부시키가이샤 |
항 her3 항체-약물 콘주게이트 투여에 의한 egfr-tki 저항성의 비소세포 폐암의 치료 방법
|
|
NZ756323A
(en)
|
2017-02-28 |
2022-07-01 |
Seagen Inc |
Cysteine mutated antibodies for conjugation
|
|
MX2019010769A
(es)
*
|
2017-03-24 |
2019-12-11 |
Seattle Genetics Inc |
Proceso para la preparacion de enlazadores de farmacos de glucuronidos y compuestos intermediarios de los mismos.
|
|
TW201836647A
(zh)
|
2017-04-06 |
2018-10-16 |
美商艾伯維有限公司 |
抗－ｐｒｌｒ抗體藥物軛合物（ａｄｃ）及其用途
|
|
HRP20221063T1
(hr)
|
2017-04-18 |
2022-11-11 |
Medimmune Limited |
Konjugati pirolobenzodiazepina
|
|
PL3612234T3
(pl)
|
2017-04-20 |
2024-09-02 |
Adc Therapeutics Sa |
Terapia skojarzona z koniugatem anty-AXL przeciwciało-lek
|
|
JOP20190245A1
(ar)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
أنظمة توصيل إطلاق مستدام تتضمن روابط بلا أثر لنقطة الربط
|
|
US11932650B2
(en)
|
2017-05-11 |
2024-03-19 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
US20200299400A1
(en)
|
2017-05-25 |
2020-09-24 |
Bristol-Myers Squibb Company |
Antibodies comprising modified heavy constant regions
|
|
WO2018229222A1
(en)
|
2017-06-14 |
2018-12-20 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-cd19 adc
|
|
MX2019015057A
(es)
|
2017-06-23 |
2020-08-03 |
Velosbio Inc |
Inmunoconjugados de anticuerpos receptor huérfano similar al receptor tirosina cinasa 1 (ror1).
|
|
GB201711809D0
(en)
|
2017-07-21 |
2017-09-06 |
Governors Of The Univ Of Alberta |
Antisense oligonucleotide
|
|
CA3070446A1
(en)
|
2017-07-25 |
2019-01-31 |
Immutics, Inc. |
Treating cancer by blocking the interaction of tim-3 and its ligand
|
|
CN111065638B
(zh)
|
2017-08-18 |
2021-04-09 |
麦迪穆有限责任公司 |
吡咯并苯并二氮杂䓬缀合物
|
|
JP2020532543A
(ja)
*
|
2017-09-02 |
2020-11-12 |
アッヴィ・インコーポレイテッド |
抗ｅｇｆｒ抗体薬物コンジュゲート（ａｄｃ）及びその使用
|
|
IL302943A
(en)
|
2017-09-20 |
2023-07-01 |
Ph Pharma Co Ltd |
Thylanstatin analogs
|
|
WO2019065964A1
(ja)
|
2017-09-29 |
2019-04-04 |
第一三共株式会社 |
抗体－ピロロベンゾジアゼピン誘導体コンジュゲート
|
|
CA3077213A1
(en)
|
2017-10-04 |
2019-04-11 |
Avidity Biosciences, Inc. |
Nucleic acid-polypeptide compositions and uses thereof
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
WO2019094904A1
(en)
*
|
2017-11-13 |
2019-05-16 |
The Regents Of The University Of California |
Compositions and methods for enhancing visual function
|
|
EP3710066B1
(en)
|
2017-11-14 |
2022-06-08 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
US11638760B2
(en)
|
2017-11-27 |
2023-05-02 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepine antibody conjugates
|
|
CN118638788A
(zh)
|
2017-12-06 |
2024-09-13 |
艾维迪提生物科学公司 |
治疗肌萎缩和强直性肌营养不良的组合物和方法
|
|
KR20200110745A
(ko)
|
2017-12-15 |
2020-09-25 |
주노 쎄러퓨티크스 인코퍼레이티드 |
항 - ｃｃｔ5 결합 분자 및 이의 사용 방법
|
|
EP3727463A1
(en)
|
2017-12-21 |
2020-10-28 |
Mersana Therapeutics, Inc. |
Pyrrolobenzodiazepine antibody conjugates
|
|
GB201721802D0
(en)
*
|
2017-12-22 |
2018-02-07 |
Almac Discovery Ltd |
Ror1-specific antigen binding molecules
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
MX2020010110A
(es)
|
2018-03-28 |
2020-11-06 |
Mitsubishi Tanabe Pharma Corp |
Conjugados de farmacos de agentes de union monoclonales de cmet, y usos de los mismos.
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2020023871A1
(en)
|
2018-07-27 |
2020-01-30 |
Promega Corporation |
Quinone-containing conjugates
|
|
BR112021005246A2
(pt)
|
2018-09-20 |
2021-06-15 |
Daiichi Sankyo Company, Limited |
agente terapêutico, e, método de tratamento para câncer
|
|
KR20210091711A
(ko)
|
2018-11-14 |
2021-07-22 |
다이이찌 산쿄 가부시키가이샤 |
항 cdh6 항체-피롤로벤조디아제핀 유도체 컨쥬게이트
|
|
CN113348177A
(zh)
|
2018-11-28 |
2021-09-03 |
百时美施贵宝公司 |
包含经修饰的重链恒定区的抗体
|
|
SI3886914T1
(sl)
|
2018-11-30 |
2023-06-30 |
Bristol-Myers Squibb Company |
Protitelo, ki vsebuje C-terminalni podaljšek lahke verige, ki vsebuje glutamin, njegove konjugate ter metode in uporabe
|
|
JP7514836B2
(ja)
|
2018-12-12 |
2024-07-11 |
ブリストル－マイヤーズ スクイブ カンパニー |
トランスグルタミナーゼによるコンジュゲーションのための改変抗体、ならびにそのコンジュゲート、方法および用途
|
|
US20220347309A1
(en)
|
2018-12-19 |
2022-11-03 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine resistance
|
|
GB201820725D0
(en)
|
2018-12-19 |
2019-01-30 |
Adc Therapeutics Sarl |
Pyrrolobenzodiazepine resistance
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
US20220096641A1
(en)
*
|
2019-01-03 |
2022-03-31 |
Legochem Biosciences, Inc. |
Pyrrolobenzodiazepine dimer compound with improved safety and use thereof
|
|
EP3918323A4
(en)
|
2019-01-30 |
2022-12-28 |
TrueBinding, Inc. |
ANTI-GAL3 ANTIBODIES AND USES THEREOF
|
|
GB201902495D0
(en)
*
|
2019-02-25 |
2019-04-10 |
Medimmune Ltd |
Methods of synthesis and intermediates
|
|
AU2020242747B2
(en)
*
|
2019-03-15 |
2025-09-18 |
Medimmune Limited |
Azetidobenzodiazepine dimers and conjugates comprising them for use in the treatment of cancer
|
|
JP2022527449A
(ja)
*
|
2019-03-21 |
2022-06-02 |
イミュノジェン・インコーポレーテッド |
細胞結合剤－薬物複合体の調製方法
|
|
US20220177601A1
(en)
|
2019-03-25 |
2022-06-09 |
Daiichi Sankyo Company, Limited |
Anti-her2 antibody-pyrrolobenzodiazepine derivative conjugate
|
|
TWI856078B
(zh)
|
2019-03-25 |
2024-09-21 |
日商第一三共股份有限公司 |
抗體–吡咯并苯二氮呯衍生物結合物、其製造方法及其用途
|
|
WO2020196712A1
(ja)
|
2019-03-27 |
2020-10-01 |
第一三共株式会社 |
抗体－ピロロベンゾジアゼピン誘導体コンジュゲートとｐａｒｐ阻害剤の組み合わせ
|
|
US12497615B2
(en)
|
2019-04-25 |
2025-12-16 |
Avidity Biosciences, Inc. |
Nucleic acid compositions and methods of multi-exon skipping
|
|
WO2020247054A1
(en)
|
2019-06-05 |
2020-12-10 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
KR20220024419A
(ko)
|
2019-06-06 |
2022-03-03 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩티드 조성물 및 이의 용도
|
|
JP7581252B2
(ja)
|
2019-06-06 |
2024-11-12 |
アビディティー バイオサイエンシーズ，インク． |
Ｕｎａアミダイトおよびその使用
|
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CN114502593A
(zh)
|
2019-08-06 |
2022-05-13 |
葛兰素史密斯克莱知识产权发展有限公司 |
生物药物组合物和相关方法
|
|
CN113330029A
(zh)
*
|
2019-08-19 |
2021-08-31 |
沈阳药科大学 |
抗体的突变体及其应用
|
|
WO2021055306A1
(en)
|
2019-09-16 |
2021-03-25 |
Bristol-Myers Squibb Company |
Dual capture method for analysis of antibody-drug conjugates
|
|
US20240123081A1
(en)
|
2019-10-25 |
2024-04-18 |
Medimmune, Llc |
Branched moiety for use in conjugates
|
|
EP4069749A4
(en)
|
2019-12-06 |
2023-12-20 |
TrueBinding, Inc. |
ANTIBODIES DISRUPTING THE INTERACTION OF GAL3 AND THE INSULIN RECEPTOR OR INTEGRINS AND THEIR METHODS OF USE
|
|
WO2021188390A1
(en)
|
2020-03-19 |
2021-09-23 |
Avidity Biosciences, Inc. |
Compositions and methods of treating facioscapulohumeral muscular dystrophy
|
|
JP7748962B2
(ja)
|
2020-03-27 |
2025-10-03 |
アビディティー バイオサイエンシーズ，インク． |
筋ジストロフィーを処置するための組成物および方法
|
|
JP2023526282A
(ja)
|
2020-05-13 |
2023-06-21 |
ボナム セラピューティクス，インク． |
タンパク質複合体の組成物及びその使用方法
|
|
CA3185040A1
(en)
|
2020-05-26 |
2021-12-02 |
Truebinding, Inc. |
Methods of treating inflammatory diseases by blocking galectin-3
|
|
AU2021307257A1
(en)
|
2020-07-17 |
2023-03-09 |
Daiichi Sankyo Company, Limited |
Method for producing antibody-drug conjugate
|
|
JP7798773B2
(ja)
|
2020-09-02 |
2026-01-14 |
第一三共株式会社 |
新規エンド－β－Ｎ－アセチルグルコサミニダーゼ
|
|
AU2022207708A1
(en)
|
2021-01-13 |
2023-07-27 |
Daiichi Sankyo Company, Limited |
Antibody-pyrrolobenzodiazepine derivative conjugate
|
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US20250026838A1
(en)
|
2021-07-13 |
2025-01-23 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
KR20240040786A
(ko)
|
2021-08-03 |
2024-03-28 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
생물제약 조성물 및 안정한 동위원소 표지 펩티드 맵핑 방법
|
|
EP4401792A4
(en)
|
2021-09-16 |
2025-12-03 |
Avidity Biosciences Inc |
COMPOSITIONS AND METHODS OF TREATMENT OF FACIO-SCAPULO-HUMERAL MUSCULAR DYSTROPHY
|
|
US20230279120A1
(en)
|
2021-11-09 |
2023-09-07 |
Truebinding, Inc. |
Methods of treating or inhibiting cardiovascular diseases
|
|
JPWO2023100829A1
(enExample)
|
2021-11-30 |
2023-06-08 |
|
|
|
AU2022422149A1
(en)
|
2021-12-23 |
2024-08-01 |
Mirecule, Inc. |
Compositions for delivery of polynucleotides
|
|
JPWO2023153442A1
(enExample)
|
2022-02-09 |
2023-08-17 |
|
|
|
CN118804983A
(zh)
|
2022-03-02 |
2024-10-18 |
第一三共株式会社 |
含Fc分子的制造方法
|
|
US12071621B2
(en)
|
2022-04-05 |
2024-08-27 |
Avidity Biosciences, Inc. |
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
|
|
EP4512411A2
(en)
|
2022-04-07 |
2025-02-26 |
Twinpig Biolab, Inc. |
Itgb2-mediated drug delivery system
|
|
AU2023298568A1
(en)
|
2022-06-30 |
2025-01-09 |
Toray Industries, Inc. |
Pharmaceutical composition for cancer treatment and/or prevention
|
|
CA3261203A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
COMPOSITIONS AND METHODS OF ADMINISTRATION MEDIATED BY THE TRANSFERRIN RECEPTOR (TFR) TO THE BRAIN AND MUSCLE
|
|
JP2025538220A
(ja)
|
2022-11-14 |
2025-11-26 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
アストロサイトへの線維芽細胞増殖因子受容体３媒介送達のための組成物および方法
|
|
CN121219016A
(zh)
|
2023-06-02 |
2025-12-26 |
第一三共株式会社 |
抗-her3抗体-药物缀合物和rasg12c抑制剂的组合
|
|
US12491257B2
(en)
|
2023-06-27 |
2025-12-09 |
Avidity Biosciences, Inc. |
Compositions and methods of using PRKAG2-targeting antibody-oligonucleotide conjugates
|
|
US12409230B2
(en)
|
2023-06-30 |
2025-09-09 |
Avidity Biosciences, Inc. |
Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy
|
|
WO2025096716A1
(en)
|
2023-11-01 |
2025-05-08 |
Incyte Corporation |
Anti-mutant calreticulin (calr) antibody-drug conjugates and uses thereof
|